Aim Immunotech Stock Technical Analysis
| AIM Stock | USD 1.19 0.04 3.48% |
As of the 19th of February, AIM ImmunoTech shows the Risk Adjusted Performance of 0.0047, mean deviation of 5.46, and Coefficient Of Variation of (17,819). AIM ImmunoTech technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm AIM ImmunoTech standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and kurtosis to decide if AIM ImmunoTech is priced adequately, providing market reflects its regular price of 1.19 per share. Given that AIM ImmunoTech is a hitting penny stock territory we recommend to closely look at its jensen alpha.
AIM ImmunoTech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as AIM, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AIMAIM ImmunoTech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.AIM ImmunoTech Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 13.99 | Strong Buy | 2 | Odds |
Most AIM analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand AIM stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of AIM ImmunoTech, talking to its executives and customers, or listening to AIM conference calls.
Will Biotechnology sector continue expanding? Could AIM diversify its offerings? Factors like these will boost the valuation of AIM ImmunoTech. If investors know AIM will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AIM ImmunoTech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (18.16) | Revenue Per Share | Quarterly Revenue Growth (0.26) | Return On Assets | Return On Equity |
AIM ImmunoTech's market price often diverges from its book value, the accounting figure shown on AIM's balance sheet. Smart investors calculate AIM ImmunoTech's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since AIM ImmunoTech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that AIM ImmunoTech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AIM ImmunoTech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, AIM ImmunoTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
AIM ImmunoTech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AIM ImmunoTech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AIM ImmunoTech.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in AIM ImmunoTech on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding AIM ImmunoTech or generate 0.0% return on investment in AIM ImmunoTech over 90 days. AIM ImmunoTech is related to or competes with Kala Pharmaceuticals, Oragenics, Pasithea Therapeutics, Vyne Therapeutics, Quoin Pharmaceuticals, Ensysce Biosciences, and XTL Biopharmaceutica. AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple... More
AIM ImmunoTech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AIM ImmunoTech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AIM ImmunoTech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 66.23 | |||
| Value At Risk | (10.32) | |||
| Potential Upside | 10.14 |
AIM ImmunoTech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AIM ImmunoTech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AIM ImmunoTech's standard deviation. In reality, there are many statistical measures that can use AIM ImmunoTech historical prices to predict the future AIM ImmunoTech's volatility.| Risk Adjusted Performance | 0.0047 | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.04) |
AIM ImmunoTech February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0047 | |||
| Market Risk Adjusted Performance | (0.03) | |||
| Mean Deviation | 5.46 | |||
| Coefficient Of Variation | (17,819) | |||
| Standard Deviation | 9.49 | |||
| Variance | 90.15 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.04) | |||
| Maximum Drawdown | 66.23 | |||
| Value At Risk | (10.32) | |||
| Potential Upside | 10.14 | |||
| Skewness | 3.65 | |||
| Kurtosis | 21.53 |
AIM ImmunoTech Backtested Returns
As of now, AIM Stock is very risky. AIM ImmunoTech secures Sharpe Ratio (or Efficiency) of 0.0169, which signifies that the company had a 0.0169 % return per unit of return volatility over the last 3 months. We have found twenty-three technical indicators for AIM ImmunoTech, which you can use to evaluate the volatility of the firm. Please confirm AIM ImmunoTech's Risk Adjusted Performance of 0.0047, coefficient of variation of (17,819), and Mean Deviation of 5.46 to double-check if the risk estimate we provide is consistent with the expected return of 0.17%. AIM ImmunoTech has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.6, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AIM ImmunoTech will likely underperform. AIM ImmunoTech at this time shows a risk of 9.91%. Please confirm AIM ImmunoTech day median price, relative strength index, as well as the relationship between the kurtosis and maximum drawdown , to decide if AIM ImmunoTech will be following its price patterns.
Auto-correlation | 0.68 |
Good predictability
AIM ImmunoTech has good predictability. Overlapping area represents the amount of predictability between AIM ImmunoTech time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AIM ImmunoTech price movement. The serial correlation of 0.68 indicates that around 68.0% of current AIM ImmunoTech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.68 | |
| Spearman Rank Test | 0.68 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
AIM ImmunoTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
AIM ImmunoTech Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of AIM ImmunoTech volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About AIM ImmunoTech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of AIM ImmunoTech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of AIM ImmunoTech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on AIM ImmunoTech price pattern first instead of the macroeconomic environment surrounding AIM ImmunoTech. By analyzing AIM ImmunoTech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of AIM ImmunoTech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to AIM ImmunoTech specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2025 | 2026 (projected) | Interest Debt Per Share | 0.54 | 2.63 | 2.49 | Revenue Per Share | 0.15 | 0.13 | 0.12 |
AIM ImmunoTech February 19, 2026 Technical Indicators
Most technical analysis of AIM help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for AIM from various momentum indicators to cycle indicators. When you analyze AIM charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0047 | |||
| Market Risk Adjusted Performance | (0.03) | |||
| Mean Deviation | 5.46 | |||
| Coefficient Of Variation | (17,819) | |||
| Standard Deviation | 9.49 | |||
| Variance | 90.15 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.04) | |||
| Maximum Drawdown | 66.23 | |||
| Value At Risk | (10.32) | |||
| Potential Upside | 10.14 | |||
| Skewness | 3.65 | |||
| Kurtosis | 21.53 |
AIM ImmunoTech February 19, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as AIM stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 25,410 | ||
| Daily Balance Of Power | 0.33 | ||
| Rate Of Daily Change | 1.03 | ||
| Day Median Price | 1.18 | ||
| Day Typical Price | 1.18 | ||
| Price Action Indicator | 0.03 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AIM ImmunoTech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in AIM Stock, please use our How to Invest in AIM ImmunoTech guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Will Biotechnology sector continue expanding? Could AIM diversify its offerings? Factors like these will boost the valuation of AIM ImmunoTech. If investors know AIM will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AIM ImmunoTech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (18.16) | Revenue Per Share | Quarterly Revenue Growth (0.26) | Return On Assets | Return On Equity |
AIM ImmunoTech's market price often diverges from its book value, the accounting figure shown on AIM's balance sheet. Smart investors calculate AIM ImmunoTech's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since AIM ImmunoTech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that AIM ImmunoTech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AIM ImmunoTech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, AIM ImmunoTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.